View Profile

Luca Grisetti

Liver Cancer Unit · IRCCS De Bellis

https://researchid.co/luca.grisetti
@sanita.puglia.it
5Scopus Publications
48Google Scholar Citations
4Google Scholar h-index
1Google Scholar i10-index

Research Interests

Cancer; Oncology; Liver; HCC; Molecular biology; Immune system

Biography

Mr. Grisetti earned a Bachelor's degree in Natural Sciences from the Università degli Studi di Milano and a Master's in Functional Genomics from the Università degli Studi di Trieste, focusing on serum microRNAs as biomarkers for hepatocellular carcinoma (HCC). He completed a Ph.D. in Molecular Biomedicine at the University of Trieste, researching Aurora kinase A (AURKA) as a driver of hepatocarcinogenesis and immune evasion. After six months as a research fellow at the Italian Liver Foundation, he joined IRCCS De Bellis in Castellana Grotte, where he continues to work on liver cancer research.

Education

09/2014 – 07/2017 Milano, Italy Bachelor's degree in Natural Science, Università degli Studi di Milano, Milano, Italy 11/2020 – 05/2024 Trieste, Italy PH.D. student in molecular biomedicine, Università degli Studi di Trieste, Trieste, Italy 10/2017 – 07/2020 Trieste, Italy Master's degree in Functional Genomics, Università degli Studi di Trieste, Trieste, Italy

Recent Scopus Publications

  1. Subtype-dependent PD-L1 stability and immune context shape immunotherapy response in hepatocellular carcinoma
    Frontiers in Immunology, 2026
  2. The ncRNA-AURKA Interaction in Hepatocellular Carcinoma: Insights into Oncogenic Pathways, Therapeutic Opportunities, and Future Challenges
    Life, 2024
  3. The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer
    Cell Proliferation, 2024
  4. Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals
    Cancers, 2022
  5. MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma
    Technology in Cancer Research and Treatment, 2022

Links